ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk lifts guidance after forecast-beating 3Q profit of .91 billion
Novo Nordisk lifts guidance after forecast-beating 3Q profit of .91 billion
Announcement as on 02 November 2022

Marinus to sell rare-disease voucher to Novo Nordisk for 0 million
Shares of Marinus Pharmaceuticals Inc. gained 7.9% in premarket trading on Thursday after the company said it plans to sell its Rare Pediatric Disease Priority Review Voucher for 0 million to Novo Nordisk . Marinus CFO Steven Pfanstiel told investors i
Announcement as on 14 July 2022

Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a toug
Announcement as on 04 July 2022

Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a toug
Announcement as on 04 July 2022

Novo Nordisk's Ozempic drug gets FDA OK for 2 mg dose to treat Type-2 Diabetes
Novo Nordisk's Ozempic drug gets FDA OK for 2 mg dose to treat Type-2 Diabetes
Announcement as on 29 March 2022

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 46.2
  • 12Day Average: 45.63
  • 20Day Average: 43.53
  • 50Day Average: 40.15
  • 100Day Average: 45.83
  • 150Day Average: 47.17
  • 200Day Average: 49.11

NVO Indicators & signals

Indicator MACD (12,26,9)

45.09, 43.35, 1.67
Indicator MACD is in positive zone

Indicator ADX (14)

17.07, 33.57, 23.78
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 44.74 44.25 to 45.50 -2.31% 0.94 times
14 Thu May 2026 45.80 45.54 to 46.84 -2.72% 0.76 times
13 Wed May 2026 47.08 46.65 to 47.21 0.17% 0.57 times
12 Tue May 2026 47.00 46.29 to 47.11 1.29% 0.82 times
11 Mon May 2026 46.40 46.27 to 47.79 0.72% 1.03 times
08 Fri May 2026 46.07 45.19 to 46.14 0.59% 0.69 times
07 Thu May 2026 45.80 45.75 to 47.08 0.11% 0.97 times
06 Wed May 2026 45.75 45.53 to 47.55 -0.02% 1.49 times
06 Wed May 2026 45.76 45.53 to 47.55 1.94% 1.78 times
05 Tue May 2026 44.89 44.21 to 45.12 1.13% 1.02 times
04 Mon May 2026 44.39 43.39 to 45.02 1.16% 0.86 times
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.51 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top